What is ECT?
Electrochemotherapy is an extension to therapy that uses active substances on cutaneous or subcutaneous tumours. Non-permeant or low-permeant active substances with intracellular targets, for example cytotoxic drugs, are delivered into the cell interior via intra tumoural or intravenous electroporation based on extremely short electric pulses. The substance dose is lower than with standard treatment because the electric pulse helps the active substance get through the cell wall. Lower doses of substance mean fewer side effects.
Studies show that electrochemotherapy (ECT) is able to increase the effect of traditional chemotherapy by reducing the dose of chemodrugs, leading to greatly improved treatment results and a partial better prognosis for the cancer patient. There are no added side effects to those already related to the use of the cytotoxic drug.
Read more about the SENNEX device from the website: